Posted at 23 Sep, 00:00h in News by alic 0 Comments GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021 GenEdit, Inc., a biotechnology company with a mission to develop curative therapies through targeted in vivo delivery of genetic medicines, today announced that it has closed a $26 million Series A financing. Tags: GenEdit ShareGenEdit Announces Series A Financing and Provides Research Update at TIDES 2021&media=', 'popupwindow', 'scrollbars=yes,width=800,height=400');popUp.focus();return false"> Print page 0 Likes
Sorry, the comment form is closed at this time.